Clinical Trial Update: Simvastatin as an Augmentation Treatment for Treatment Resistant Depression: Randomized Controlled Trial. [Phase 3]

View source ↗

Summary

Phase 3 randomized controlled trial evaluating simvastatin as an augmentation therapy for treatment resistant depression and major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Pakistan Institute of Living and Learning | Conditions: Treatment Resistant Depression, Major Depressive Disorder | Phase 3 | Status: COMPLETED